These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1470571)

  • 1. Complications of polycythemia in patients who have cyanotic congenital heart disease.
    Strong WB
    Pediatr Rev; 1992 Oct; 13(10):379-80. PubMed ID: 1470571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrovascular accidents in infants and children with cyanotic congenital heart disease.
    Phornphutkul C; Rosenthal A; Nadas AS; Berenberg W
    Am J Cardiol; 1973 Sep; 32(3):329-34. PubMed ID: 4725588
    [No Abstract]   [Full Text] [Related]  

  • 3. [Iron deficiency in cyanotic heart defects: a cause of cerebral complications].
    Linderkamp O; Mayr S; Sengespeik C; Klose H; Betke K
    Monatsschr Kinderheilkd (1902); 1976 May; 124(5):301-2. PubMed ID: 934098
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathophysiologic consequences of cyanotic congenital heart disease.
    Rao PS
    Indian J Pediatr; 1983; 50(406):479-87. PubMed ID: 6674196
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of polycythaemia in adults with cyanotic congenital heart disease.
    Thorne SA
    Heart; 1998 Apr; 79(4):315-6. PubMed ID: 9616333
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of premedication on arterial oxygen saturation in children with congenital heart disease.
    DeBock TL; Davis PJ; Tome J; Petrilli R; Siewers RD; Motoyama EK
    J Cardiothorac Anesth; 1990 Aug; 4(4):425-9. PubMed ID: 2132337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sickle Cell Disease with Cyanotic Congenital Heart Disease: Long-Term Outcomes in 5 Children.
    Iannucci GJ; Adisa OA; Oster ME; McConnell M; Mahle WT
    Tex Heart Inst J; 2016 Dec; 43(6):509-513. PubMed ID: 28100970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron deficiency in a patient with extreme erythrocytosis due to cyanotic congenital heart disease.
    Braun SL; Eicken A; Kaemmerer H
    Int J Cardiol; 2007 Mar; 116(2):e74-5. PubMed ID: 17097163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary arteriovenous fistula for the palliation of complex cyanotic congenital heart disease: is it an effective tool?
    Quiñonez LG; Brown ML; Dearani JA; Burkhart HM; Puga FJ
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):188-92. PubMed ID: 20619423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Normal hemoglobin levels in children with cyanotic heart disease. Is it iron deficiency anemia?].
    Hågå P
    Tidsskr Nor Laegeforen; 1993 May; 113(14):1710-1. PubMed ID: 8322297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypochromic polyglobulia in infants and children with cyanotic heart defects. 3. Recommendations on iron therapy].
    Adrian B; Bartel J; Gottschalk C; Lenk H
    Kinderarztl Prax; 1980 Sep; 48(9):470-2. PubMed ID: 7431740
    [No Abstract]   [Full Text] [Related]  

  • 12. [Central nervous system complications in patients with cyanotic congenital heart diseases (author's transl)].
    Pernot C
    Chir Pediatr; 1980; 21(1):35-40. PubMed ID: 7408065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron deficiency in children with cyanotic congenital heart disease.
    West DW; Scheel JN; Stover R; Kan J; DeAngelis C
    J Pediatr; 1990 Aug; 117(2 Pt 1):266-8. PubMed ID: 2380829
    [No Abstract]   [Full Text] [Related]  

  • 14. Cerebral vascular accidents in cyanotic congenital heart disease.
    Cottrill CM; Kaplan S
    Am J Dis Child; 1973 Apr; 125(4):484-7. PubMed ID: 4699887
    [No Abstract]   [Full Text] [Related]  

  • 15. [Incidence of anaemia in congenital heart diseases (author's transl)].
    Drossos C; Thanapoulos B; Papadimitrou T; Milingos M; Papadimitrou A; Kostantelloy E; Ikkos D
    Pediatr Med Chir; 1981; 3(4):309-12. PubMed ID: 7343922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of lowering the hematocrit on polycythemia and thrombocytopenia in congenital cyanotic heart defect].
    de Haan M; de Koning J; Ottenkamp J; Schilte PP
    Tijdschr Kindergeneeskd; 1985 Oct; 53(5):178-81. PubMed ID: 2418530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adults with cyanotic congenital heart disease: hematologic management.
    Perloff JK; Rosove MH; Child JS; Wright GB
    Ann Intern Med; 1988 Sep; 109(5):406-13. PubMed ID: 3044212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation abnormalities in patients with cyanotic congenital heart disease.
    Tempe DK; Virmani S
    J Cardiothorac Vasc Anesth; 2002 Dec; 16(6):752-65. PubMed ID: 12486661
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical update: cyanotic adult congenital heart disease.
    Spence MS; Balaratnam MS; Gatzoulis MA
    Lancet; 2007 Nov; 370(9598):1530-2. PubMed ID: 17980725
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chemotherapy against polycythemia due to a cyanotic congenital heart disease in adults. One case report].
    Boussaada R; Békir S; Ben Romdhane N; Mechmèche R
    Tunis Med; 2007 May; 85(5):437-40. PubMed ID: 17657936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.